Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Scientific and educational resources from the Congress

Abstracts 1000x250
Congress Updates
Congress Updates


Abstracts and ePosters are open access.

Read more
Meeting Resources Tablet in Hand 1000x250
Congress Updates
Congress Updates

Slides and Webcasts

Presentations (slides) and webcasts are available to ESMO members and attendees according to the presenters' agreement to release them.

Read more

All accepted abstracts, including LBAs, are online.

Slides, webcasts and ePosters are available on OncologyPRO for ESMO Members.


Anticancer agents & Biologic therapy;  Cancer Immunology and Immunotherapy;  Genitourinary cancers

Pembrolizumab Combinations Show Promise in mCRPC

All of the pembrolizumab regimens were safe in patients with metastatic castration-resistant prostate cancer

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.